Novartis' Q3 core net income surges to $3.47 billion

Swiss drugmaker Novartis said on Tuesday that third-quarter core net income was $3.47 billion, up from $3.21 billion a year ago.

Analysts polled by Refinitiv had, on average, forecast $3.2 billion.

For 2020, the Basel-based company broadened its core operating income growth forecast to low double-digit to mid-teen percentage rate growth, from a low double-digit range previously, while net sales are expected to grow in the mid-single-digit percentage range.